Related Experiment Videos
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)
K Chirgwin1, P M Roblin, M R Hammerschlag
1Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.
Antimicrobial Agents and Chemotherapy
|September 1, 1989
Abstract:
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.